Gilead’s new drug is even pricier than Sovaldi
October 10, 2014 at 15:12 PM EDT
Gilead’s new hepatitis C drug is even pricier than its $1,000-a-day Sovaldi.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.